These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 23311051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bisphosphonate-related osteonecrosis of the jaw.
    Robichaux C, Ong M, Veillon D, Patel S, Cotelingam J.
    J La State Med Soc; 2014; 166(5):200-2. PubMed ID: 25369221
    [Abstract] [Full Text] [Related]

  • 7. Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
    Tong CK, Ho ST, Wong SL.
    Hong Kong Med J; 2010 Apr; 16(2):145-8. PubMed ID: 20354251
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pseudoepitheliomatous hyperplasia associated with bisphosphonate-related osteonecrosis of the jaw.
    Zustin J, Reske D, Zrnc TA, Heiland M, Scheuer HA, Assaf AT, Friedrich RE.
    In Vivo; 2014 Apr; 28(1):125-31. PubMed ID: 24425847
    [Abstract] [Full Text] [Related]

  • 15. Bone single-photon emission computed tomography-CT peak standardized uptake value for chronic osteomyelitis, osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Minami Y, Ogura I.
    J Med Imaging Radiat Oncol; 2021 Apr; 65(2):160-165. PubMed ID: 33180378
    [Abstract] [Full Text] [Related]

  • 16. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH, Seal B, Tangirala M, Jeffcoat MK, Watts NB, Hay JW.
    Gen Dent; 2010 Apr; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [Abstract] [Full Text] [Related]

  • 17. Radiographic evaluation of maxillofacial region in oncology patients treated with bisphosphonates.
    Rocha GC, Jaguar GC, Moreira CR, Neves EG, Fonseca FP, Pedreira EN.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5 Suppl):S19-25. PubMed ID: 23083951
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate-related osteonecrosis of the jaw in a chronic hemodialysis patient.
    Gunen Yilmaz S, Yılmaz F.
    Saudi J Kidney Dis Transpl; 2018 Nov; 29(1):223-224. PubMed ID: 29456237
    [No Abstract] [Full Text] [Related]

  • 19. Bisphosphonates, phossy jaw, and bisphosphonate-related osteonecrosis of the jaw.
    Lewis DM.
    J Okla Dent Assoc; 2011 Nov; 102(5):36-9. PubMed ID: 21874699
    [No Abstract] [Full Text] [Related]

  • 20. Bisphosphonate-related osteonecrosis of the jaws: study of the staging system in a series of clinical cases.
    Bagan JV, Hens-Aumente E, Leopoldo-Rodado M, Poveda-Roda R, Bagan L.
    Oral Oncol; 2012 Aug; 48(8):753-7. PubMed ID: 22401869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.